Member Info for KilkennyTed

Kaeran. Beware the perforations.

Primates Promote Promate. Sounds like a PG tips advert.

I prefer Cadbury over Galaxy if that's of interest to anyone.

The TVG was with regards Promate which it passed.
As far as I'm aware TF supply MK

What a pest. Everybody wave to the Captain as he'll still be reading the post's without being able to comment.
He'll be back in another form probably demoted to Cabin Boy.

I can't see a huge sell off either. The drop was well overdone and makes for some volatility which leads to a flurry of trades. If anything there looked like a good appetite from buyers, if you were lucky enough to complete a trade.Looks like a big bounce in the morning. The sale of over 12m shares would explain why the price has been static for the past couple of weeks but it's done now.

I'm happy with the 4% rise today when you look at what has happened elsewhere.

Yet Abingdon dropped less than 3%

Thats a hole new ball game

Your name is very apt HeresHopin

Nice steady start. 5% a day will do. Keep in the shadows.

What have I missed? What have we won? There seems a lot of excitement about a tender that hasn't been finalised yet.

90% 31/01/2020. Closing sp 38p

The Mologic Rapid test is the big one for Omega. Further update from Mologic expected in January. Can't be far off.

https://www.cambridgenetwork.co.uk/news/mologic-receives-ce-mark-approval-professional-use-covid-19-rapid-antigen-test
24-12-2020
Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, is pleased to announce its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM). The test will provide health professionals an accurate detection of the nucleoprotein of the SARS-CoV-2 virus in respiratory swabs, within 10 minutes. Development and validation were supported by the Wellcome Trust and the Foreign, Commonwealth and Development Office (FCDO) Joint Initiative on Research in Epidemic Preparedness and Response.

Independent assessment at Liverpool University Hospitals NHS Foundation Trust, as part of the FASTER study with 28 patients presenting for care, resulted in a sensitivity of 92%, and a specificity of 100%, corresponding to RT-qPCR-confirmed COVID-19 cases. Limit of detection studies estimate a 50% Tissue Culture Infectious Dose (TCID50/ml) of 100-350 (<5x10^2 pfu/ml), a key tool for estimating the infectious titre of a virus.

Considering the preliminary number of patients included so far, further studies are planned across the UK with St George’s University of London, Northumbria Healthcare NHS Foundation Trust, Imperial College London, Nottingham University Health Trust, and the Hull Royal Infirmary, with expected report findings in January 2021. The data is available on request, pending full publication of results.

In addition, Mologic’s COVID-19 Rapid Antigen Test has been invited to take part in the US National Institutes of Health (NIH) RADx initiative that will fast-track development, manufacture, and regulatory submissions.

Global validation trials have begun with the Institut Pasteur de Dakar in Senegal, West Africa and will commence in Boston, USA, and in Jakarta, Indonesia, from January 2021. Dossiers will be prepared for submission to the US FDA and WHO at that same time.

To guarantee access to the rapid test in low- and middle-income countries, the COVID-19 Rapid Antigen Test will be manufactured and made available by Global Access Diagnostics (GAD), at cost of production and distributed through commercialisation partners.

Bound to be a slight pullback over the next couple of day's if no news. But we are in a great position now when news does land.

Good morning all. I posted a message last night with this link but it was during someone having a mental breakdown and was swamped. It's a big read but some very interesting parts with regards of contract values already arranged & more importantly future budgets for the test and trace system. Could be a very bright future for Omega.
https://www.nao.org.uk/wp-content/uploads/2020/12/The-governments-approach-to-test-and-trace-in-England-interim-report.pdf

Not sure if this has been posted already. Very interesting read. Huge budgets for the next couple of years. Innova have already had over £600m from the supply of rapid tests.
https://www.nao.org.uk/wp-content/uploads/2020/12/The-governments-approach-to-test-and-trace-in-England-interim-report.pdf

Nice work Hillseeker. A thoroughly good read. Not sure about the rest of you, but i've packed some oxygen for the summit.

Nice work Hillseeker. A thoroughly good read. Not sure about the rest of you, but i've packed some oxygen for the summit.

Yes looks promising.